Skip to main content
. 2022 Oct 17;15(12):2899–2908. doi: 10.1111/cts.13417

FIGURE 2.

FIGURE 2

Model predictions for (a) evobrutinib 25 mg after Day 1 (single dose) and Day 6 (6× q.d. doses) while fasted; (b) evobrutinib 75 mg after Day 1 (single dose) and Day 6 (6× q.d. doses) while fasted and after Day 1 (single dose) with food; and (c) evobrutinib 200 mg after Day 1 (single dose) and Day 6 (6× q.d. doses) while fasted. LLOQ, lower limit of quantification; q.d., once‐daily.